[1]Warren S, Sommer G J, Jr.Fibrosarcoma of the soft parts: With special reference to recurrence and metastasis[J].Archives of Surgery, 1936, 33(3):425-50
[2]Pierce S M, Recht A, Lingos T I, et al.Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer[J].Int J Radiat Oncol Biol Phys, 1992, 23(5):915-23
[3]Mark R J, Poen J, Tran L M, et al.Postirradiation sarcomasA single‐institution study and review of the literature[J].Cancer, 1994, 73(10):2653-62
[4]Chen K T, Hoffman K D, Hendricks E J.Angiosarcoma following therapeutic irradiation[J].Cancer, 1979, 44(6):2044-8
[5]Edeiken S, Russo D P, Knecht J, et al.Angiosarcoma after tylectomy and radiation therapy for carcinoma of the breast[J].Cancer, 1992, 70(3):644-7
[6]De Bree E, Van Coevorden F, Peterse J, et al.Bilateral angiosarcoma of the breast after conservative treatment of bilateral invasive carcinoma: genetic predisposition?[J].European Journal of Surgical Oncology (EJSO), 2002, 28(4):392-5
[7]De Smet S, Vandermeeren L, Christiaens M-R, et al.Radiation-induced sarcoma: analysis of 46 cases[J].Acta Chir Belg, 2008, 108(5):574-9
[8] Cohen W, Woodard H, Higgenbotham N.Sarcoma arising in irradiated bone. Report of 11 cases [J]. Cancer, 1948, 1(3-29.[J].Cancer, 1948, 1(1):3-29
[9]Erel E, Vlachou E, Athanasiadou M, et al.Management of radiation-induced sarcomas in a tertiary referral centre: a review of 25 cases[J].The Breast, 2010, 19(5):424-7
[10] Quadros C A, Vasconcelos A, Andrade R, et al.Good outcome after neoadjuvant chemotherapy and extended surgical resection for a large radiation-induced high-grade breast sarcoma; proceedings of the International Seminars in Surgical Oncology, F, 2006 [C]. BioMed Central Ltd.
[11]Strobbe L J, Peterse H L, van Tinteren H, et al.Angiosarcoma of the breast after conservation therapy for invasive cancer,the incidence and outcomeAn unforeseen sequela[J].Breast Cancer Research and Treatment, 1998, 47(2):101-9
[12]Brady M S, Gaynor J J, Brennan M F.Radiation-associated sarcoma of bone and soft tissue[J].Archives of Surgery, 1992, 127(12):1379-85
[13]Barrow B J, Janjan N A, Gutman H, et al.Role of radiotherapy in sarcoma of the breast–a retrospective review of the MD Anderson experience[J].Radiotherapy and oncology, 1999, 52(2):173-8
[14]Bjerkehagen B, Smeland S, Walberg L, et al.Radiation-induced sarcoma: 25-year experience from the Norwegian Radium Hospital[J].Acta Oncologica, 2008, 47(8):1475-82
[15]Cha C, Antonescu C R, Quan M L, et al.Long-term results with resection of radiation-induced soft tissue sarcomas[J].annals of surgery, 2004, 239(6):903-9
[16]Rao J, DeKoven J G, Beatty J D, et al.Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast[J].Journal of the American Academy of Dermatology, 2003, 49(3):532-8
[17]Fant J, Grant M, May S, et al.Angiosarcoma of the breast: Mammographic,clinical,and pathologic correlation[J].The breast journal, 2003, 9(3):252-3
[18]Thijssens K M, van Ginkel R J, Suurmeijer A J, et al.Radiation-induced sarcoma: a challenge for the surgeon[J].Annals of Surgical Oncology, 2005, 12(3):237-45
[19]Adhikari D, Hajdu S I, Levine D.Post-radiation angiosarcoma and bilateral mastectomy[J].Annals of Clinical & Laboratory Science, 2002, 32(4):428-33
[20]Lagrange J-L, Ramaioli A, Chateau M-C, et al.Sarcoma after Radiation Therapy: Retrospective Multiinstitutional Study of 80 Histologically Confirmed Cases 1[J].Radiology, 2000, 216(1):197-205
[21]Rosen P P, Kimmel M, Ernsberger D.Mammary angiosarcoma: the prognostic significance of tumor differentiation[J].Cancer, 1988, 62(10):2145-51
[22]Yap B S, Yap H Y, McBride C M, et al.Chemotherapy for postmastectomy lymphangiosarcoma[J].Cancer, 1981, 47(5):853-6
[23]Mano M S, Fraser G, Kerr J, et al.Radiation-induced angiosarcoma of the breast shows major response to docetaxel after failure of anthracycline-based chemotherapy[J].The Breast, 2006, 15(1):117-8
[24]Van Glabbeke M, Van Oosterom A, Oosterhuis J, et al.Prognostic factors for the outcome of chemotherapy in advanced soft tissue sarcoma: an analysis of 2,185 patients treated with anthracycline-containing first-line regimens—a European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study[J].Journal of Clinical Oncology, 1999, 17(1):150-7
[25]Sleijfer S, Ouali M, van Glabbeke M, et al.Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas: an exploratory,retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG)[J].Eur J Cancer, 2010, 46(1):72-83
[26]Antman K, Crowley J, Balcerzak S P, et al.An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas[J].Journal of Clinical Oncology, 1993, 11(7):1276-85
[27]Edmonson J, Ryan L, Blum R, et al.Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin,doxorubicin,and cisplatin against advanced soft tissue sarcomas[J].Journal of Clinical Oncology, 1993, 11(7):1269-75
[28]Feigenberg S J, Mendenhall N P, Reith J D, et al.Angiosarcoma after breast-conserving therapy: experience with hyperfractionated radiotherapy[J].Int J Radiat Oncol Biol Phys, 2002, 52(3):620-6
[29]Palta M, Morris C G, Grobmyer S R, et al.Angiosarcoma after breast‐conserving therapy[J].Cancer, 2010, 116(8):1872-8
[30]Givens S S, Woo S Y, Huang L, et al.Non-metastatic Ewing's sarcoma: twenty years of experience suggests that surgery is a prime factor for successful multimodality therapy[J].International journal of oncology, 1999, 14(6):1039-82
[31]Sheth G R, Cranmer L D, Smith B D, et al.Radiation-induced sarcoma of the breast: a systematic review[J].Oncologist, 2012, 17(3):405-18